Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             160 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials Xie, Fang
2012
4 p. 739-748
10 p.
artikel
2 A cluster randomised controlled trial of pharmacist led Statin Outreach Support (SOS) in primary care: Design and baseline characteristics Lowrie, Richard
2010
4 p. 303-311
9 p.
artikel
3 A comparison of methods and results in recruiting white and black women into reproductive studies: The MMC–PSU cooperative center on reproduction experience Sweet, Stephanie
2008
4 p. 478-481
4 p.
artikel
4 A comparison of two internet programs for adolescents with type 1 diabetes: Design and methods Grey, Margaret
2012
4 p. 769-776
8 p.
artikel
5 A comparison of two worlds: How does Bayes hold up to the status quo for the analysis of clinical trials? Pressman, Alice R.
2011
4 p. 561-568
8 p.
artikel
6 Acupuncture for dysphagia after chemoradiation in head and neck cancer: Rationale and design of a randomized, sham-controlled trial Lu, Weidong
2012
4 p. 700-711
12 p.
artikel
7 A dynamic block-randomization algorithm for group-randomized clinical trials when the composition of blocking factors is not known in advance Bellamy, Scarlett L.
2005
4 p. 469-479
11 p.
artikel
8 A likelihood approach to analyzing clinical trial data when treatments favor different outcomes McClure, Leslie Ain
2006
4 p. 340-352
13 p.
artikel
9 Alternative designs of phase II trials considering response and toxicity Jin, Hua
2007
4 p. 525-531
7 p.
artikel
10 A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction Blasey, Christine M.
2009
4 p. 284-288
5 p.
artikel
11 An adaptive approach for bivariate phase II clinical trial designs Wu, Chengqing
2007
4 p. 482-486
5 p.
artikel
12 Analysis of a crossover clinical trial by permutation methods Good, Phillip
2008
4 p. 565-568
4 p.
artikel
13 Analysis of duration of response in oncology trials Ellis, Stuart
2008
4 p. 456-465
10 p.
artikel
14 Analyzing the duration of recurrent events in clinical trials: A comparison of approaches using data from the UK700 trial of psychiatric case management Metcalfe, Chris
2005
4 p. 443-458
16 p.
artikel
15 An analysis of current pharmaceutical industry practices for making clinical trial results publicly accessible Viereck, Christopher
2009
4 p. 293-299
7 p.
artikel
16 A non-inferiority test of areas under two parametric ROC curves Jin, Hua
2009
4 p. 375-379
5 p.
artikel
17 An online randomised controlled trial to assess the feasibility, acceptability and potential effectiveness of ‘Living with Bipolar’: A web-based self-management intervention for Bipolar Disorder Todd, Nicholas J.
2012
4 p. 679-688
10 p.
artikel
18 A permutation test for a weighted Kaplan–Meier estimator with application to the nutritional prevention of cancer trial Frankel, Paul H.
2007
4 p. 343-347
5 p.
artikel
19 A randomized, controlled, supervised, exercise trial in young overweight men and women: The Midwest Exercise Trial II (MET2) Donnelly, Joseph E.
2012
4 p. 804-810
7 p.
artikel
20 A randomized controlled trial of acupuncture and moxibustion to treat Bell's palsy according to different stages: Design and protocol Chen, Xiaoqin
2009
4 p. 347-353
7 p.
artikel
21 A randomized trial to assess the effect of a research informational pamphlet on telephone survey completion rates among older Latinos Santoyo-Olsson, Jasmine
2012
4 p. 624-627
4 p.
artikel
22 A rationale and method for high-intensity progressive resistance training with children and adolescents Benson, Amanda C.
2007
4 p. 442-450
9 p.
artikel
23 Are those who join a trial in response to a scarcity message more likely to drop out? Devries, Karen M.
2011
4 p. 475-
1 p.
artikel
24 Articles with high-grade evidence: Trend in the last decade Rahman, Mahbubur
2005
4 p. 510-511
2 p.
artikel
25 Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: Rationale and design of the SLAM DUNC Study Pence, Brian W.
2012
4 p. 828-838
11 p.
artikel
26 Assessment of blinding may be inappropriate after the trial Hemilä, Harri
2005
4 p. 512-514
3 p.
artikel
27 Association between interactive voice response adherence and subject retention in a randomized controlled trial Gatehouse, Christopher S.
2012
4 p. 589-592
4 p.
artikel
28 A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty Dominguez-Rodriguez, Alberto
2007
4 p. 532-539
8 p.
artikel
29 Balancing multiple baseline characteristics in randomized clinical trials Su, Zheng
2011
4 p. 547-550
4 p.
artikel
30 Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial Zohar, Sarah
2008
4 p. 608-616
9 p.
artikel
31 Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials Daimon, Takashi
2008
4 p. 507-516
10 p.
artikel
32 Cancer: A disease of chaos? — Flash lights Armbruster, Christine
2009
4 p. 283-
1 p.
artikel
33 Can regional analgesia reduce the risk of recurrence after breast cancer? Sessler, Daniel I
2008
4 p. 517-526
10 p.
artikel
34 Clinical trials and the response rate illusion Kirsch, Irving
2007
4 p. 348-351
4 p.
artikel
35 Clinical trials attitudes and practices of Latino physicians Ramirez, Amelie G.
2008
4 p. 482-492
11 p.
artikel
36 Cluster randomized trials of cancer screening interventions: Are appropriate statistical methods being used? Crespi, Catherine M.
2011
4 p. 477-484
8 p.
artikel
37 Cognitive testing in early-phase clinical trials: Development of a rapid computerized test battery and application in a simulated Phase I study Collie, Alex
2007
4 p. 391-400
10 p.
artikel
38 Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: Design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up Jarrett, Robin B.
2010
4 p. 355-377
23 p.
artikel
39 Comparison of paper-based and electronic data collection process in clinical trials: Costs simulation study Pavlović, Ivan
2009
4 p. 300-316
17 p.
artikel
40 Compliance in a school-based caries clinical trial of a sugar-free chewing gum Bailey, Denise Louise
2011
4 p. 492-497
6 p.
artikel
41 Costs of recruiting couples to a clinical trial Sadler, Georgia Robins
2007
4 p. 423-432
10 p.
artikel
42 Creating a culture of research Avins, Andrew L.
2007
4 p. 557-562
6 p.
artikel
43 CTN-194 (PICCO): Design of a trial of citalopram for the prevention of depression and its consequences in HIV-Hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy Klein, Marina B.
2008
4 p. 617-630
14 p.
artikel
44 Current situation of clinical trials in Beijing, China Yoshida, Yoshitoku
2012
4 p. 583-588
6 p.
artikel
45 Current status of quality in Japanese clinical trials Saito, Kazuyuki
2005
4 p. 503-509
7 p.
artikel
46 Data acquisition for a patient-directed intervention protocol in the dynamic intensive care unit setting Chlan, Linda
2011
4 p. 544-546
3 p.
artikel
47 Design and baseline characteristics of the Soy Phytoestrogens As Replacement Estrogen (SPARE) study — A clinical trial of the effects of soy isoflavones in menopausal women Levis, Silvina
2010
4 p. 293-302
10 p.
artikel
48 Design and implementation of the Exercise for Health trial — A pragmatic exercise intervention for women with breast cancer Hayes, Sandra
2011
4 p. 577-585
9 p.
artikel
49 Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): A cluster randomized trial Margolis, Karen L.
2012
4 p. 794-803
10 p.
artikel
50 Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder Goodrich, David E.
2012
4 p. 666-678
13 p.
artikel
51 Designing clinical trials and experiments efficiently with the program package CADEMO Rasch, Dieter
2009
4 p. 354-365
12 p.
artikel
52 Determination of required content of the informed consent process for human participants in biomedical research conducted in the U.S.: A practical tool to assist clinical investigators Chanaud, Cheryl M.
2008
4 p. 501-506
6 p.
artikel
53 Diabetes nurse case management and motivational interviewing for change (DYNAMIC): Study design and baseline characteristics in the Chronic Care Model for type 2 diabetes Stuckey, Heather L.
2009
4 p. 366-374
9 p.
artikel
54 Differences in recruitment and early retention among ethnic minority participants in a large pediatric cohort: The TEDDY Study Baxter, Judith
2012
4 p. 633-640
8 p.
artikel
55 Diversity in Research: Clinical trials for all people Drennan, Kathleen B.
2010
4 p. 271-
1 p.
artikel
56 Do “placebo responders” exist? Kaptchuk, Ted J.
2008
4 p. 587-595
9 p.
artikel
57 Dose-finding designs in pediatric phase I clinical trials: Comparison by simulations in a realistic timeline framework Doussau, A.
2012
4 p. 657-665
9 p.
artikel
58 Drop-out rates of cancer patients participating in longitudinal RCTs Mathibe, Lehlohonolo J.
2007
4 p. 340-342
3 p.
artikel
59 Early phase drug development for treatment of chronic pain — Options for clinical trial and program design Kalliomäki, Jarkko
2012
4 p. 689-699
11 p.
artikel
60 Economic benefits of sponsored clinical trials on pharmaceutical expenditures at a medical center in Taiwan Shen, Li-Jiuan
2011
4 p. 485-491
7 p.
artikel
61 Editorial Board 2009
4 p. iii-
1 p.
artikel
62 Editorial Board 2005
4 p. iii-
1 p.
artikel
63 Editorial Board 2006
4 p. iii-
1 p.
artikel
64 Editorial Board 2008
4 p. iii-
1 p.
artikel
65 Editorial Board 2010
4 p. iii-
1 p.
artikel
66 Editorial Board 2007
4 p. iii-
1 p.
artikel
67 Editorial Board 2011
4 p. iii-
1 p.
artikel
68 Editorial Board 2012
4 p. iii-
1 p.
artikel
69 Effect of imbalance and intracluster correlation coefficient in cluster randomization trials with binary outcomes when the available number of clusters is fixed in advance Ahn, Chul
2009
4 p. 317-320
4 p.
artikel
70 Effect of trans fatty acid isomers from ruminant sources on risk factors of cardiovascular disease: Study design and rationale Gebauer, Sarah K.
2011
4 p. 569-576
8 p.
artikel
71 Effects of an exercise intervention on other health behaviors in overweight/obese post-menopausal women Rhew, Isaac
2007
4 p. 472-481
10 p.
artikel
72 Effects of testosterone supplementation on clinical and rehabilitative outcomes in older men undergoing on-pump CABG Maggio, Marcello
2012
4 p. 730-738
9 p.
artikel
73 Enrollment experiences in a pediatric longitudinal observational study: The Environmental Determinants of Diabetes in the Young (TEDDY) study Lernmark, Barbro
2011
4 p. 517-523
7 p.
artikel
74 Estimating per patient funding for cancer clinical trials: An Ontario based survey Wright, James R.
2005
4 p. 421-429
9 p.
artikel
75 Estimating sample size for a randomized clinical trial of lung cancer screening Obuchowski, Nancy A.
2008
4 p. 466-477
12 p.
artikel
76 Ethical issues in clinical trials involving nanomedicine Resnik, David B.
2007
4 p. 433-441
9 p.
artikel
77 Evaluating a two-step approach to sexual risk reduction in a publicly-funded STI clinic: Rationale, design, and baseline data from the Health Improvement Project-Rochester (HIP-R) Carey, Michael P.
2008
4 p. 569-586
18 p.
artikel
78 Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials Chen, Yeh-Fong
2011
4 p. 592-604
13 p.
artikel
79 Exploring the association between lifetime physical activity and pelvic floor disorders: Study and design challenges Nygaard, Ingrid
2012
4 p. 819-827
9 p.
artikel
80 Flexible design of two-stage adaptive procedures for phase III clinical trials Koyama, Tatsuki
2007
4 p. 500-513
14 p.
artikel
81 Group interventions for co-morbid insomnia and osteoarthritis pain in primary care: The lifestyles cluster randomized trial design Von Korff, Michael
2012
4 p. 759-768
10 p.
artikel
82 Healthy eating, aerobic and resistance training in youth (HEARTY): Study rationale, design and methods Alberga, A.S.
2012
4 p. 839-847
9 p.
artikel
83 Healthy Moms, a randomized trial to promote and evaluate weight maintenance among obese pregnant women: Study design and rationale Vesco, Kimberly K.
2012
4 p. 777-785
9 p.
artikel
84 Implementing a palm pilot intervention for primary care providers: Lessons learned Rosenberger, Erica L.
2009
4 p. 321-325
5 p.
artikel
85 Increasing Asian American women's research participation: The Asian grocery store-based cancer education program Sadler, Georgia Robins
2010
4 p. 283-288
6 p.
artikel
86 Information for Authors 2005
4 p. I-II
nvt p.
artikel
87 Information for Authors 2006
4 p. I-II
nvt p.
artikel
88 In search of the sample: Recent experiences of a trial team in Orthodontics Cunningham, Susan
2011
4 p. 530-534
5 p.
artikel
89 Insurance and clinical trials Minacori, Roberta
2012
4 p. 573-
1 p.
artikel
90 Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: The design of the TEAMcare study Katon, Wayne
2010
4 p. 312-322
11 p.
artikel
91 Intestinal microbiota and its effect on the immune system — A nested case-cohort study on prevention of atopy among small children in Trondheim: The IMPACT study Øien, Torbjørn
2006
4 p. 389-395
7 p.
artikel
92 Issues in recruiting community-dwelling stroke survivors to clinical trials: The AMBULATE trial Lloyd, Gemma
2010
4 p. 289-292
4 p.
artikel
93 Keep it off: A phone-based intervention for long-term weight-loss maintenance Sherwood, Nancy E.
2011
4 p. 551-560
10 p.
artikel
94 Letter from the Editor Getz, Kenneth
2005
4 p. 419-420
2 p.
artikel
95 Letter to the Editor Nadarajah, Saralees
2007
4 p. 337-339
3 p.
artikel
96 Measuring improved targeting of health interventions to the poor in the context of a community-randomised trial in rural India Morris, Saul S.
2007
4 p. 382-390
9 p.
artikel
97 Methods of joint evaluation of efficacy and toxicity in phase II clinical trials Tournoux, Caroline
2007
4 p. 514-524
11 p.
artikel
98 Minority recruitment into clinical trials: Experimental findings and practical implications Brown, Susan D.
2012
4 p. 620-623
4 p.
artikel
99 Mobile diabetes intervention study: Testing a personalized treatment/behavioral communication intervention for blood glucose control Quinn, Charlene C.
2009
4 p. 334-346
13 p.
artikel
100 Modelling overdispersion in longitudinal count data in clinical trials with application to epileptic data Fotouhi, Ali Reza
2008
4 p. 547-554
8 p.
artikel
101 MRI in clinical trial: Appropriateness? Wiwanitkit, Viroj
2011
4 p. 476-
1 p.
artikel
102 Non-frozen transports of whole blood samples do not cause relevant bias for global coagulation tests in clinical trials evaluating the drug safety Totzke, Uwe
2005
4 p. 488-502
15 p.
artikel
103 [No title] Henneicke-von Zepelin, H.-H.
2005
4 p. 512-
1 p.
artikel
104 [No title] Collins, Joseph F.
2008
4 p. 455-
1 p.
artikel
105 Potential of melatonin for the treatment or prevention of obesity: An urgent need to include weight reduction as a secondary outcome in clinical trials of melatonin in obese patients with sleep disorders Rastmanesh, Reza
2012
4 p. 574-575
2 p.
artikel
106 Power and sample size simulations for Randomized Play-the-Winner rules Guimaraes, Paulo
2007
4 p. 487-499
13 p.
artikel
107 Predicting where future means will lie based on the results of the current trial Julious, Steven A.
2007
4 p. 352-357
6 p.
artikel
108 Prediction of Arrhythmic Events with Positron Emission Tomography: PAREPET study design and methods Fallavollita, James A.
2006
4 p. 374-388
15 p.
artikel
109 Presentation in relation to publication of results from clinical trials Ünalp, Aynur
2007
4 p. 358-369
12 p.
artikel
110 Pre-trial evaluation of the potential for unblinding in drug trials: A prototype example Walter, S.D.
2005
4 p. 459-468
10 p.
artikel
111 Preventing cognitive decline in older African Americans with mild cognitive impairment: Design and methods of a randomized clinical trial Rovner, Barry W.
2012
4 p. 712-720
9 p.
artikel
112 Proactive recruitment of cancer patients' social networks into a smoking cessation trial Bastian, Lori A.
2011
4 p. 498-504
7 p.
artikel
113 PRODIACOR: A patient-centered treatment program for type 2 diabetes and associated cardiovascular risk factors in the city of Corrientes, Argentina Gagliardino, J.J.
2007
4 p. 548-556
9 p.
artikel
114 Randomisation in double-blind multicentre trials with many treatments Morrissey, Malcolm
2010
4 p. 381-391
11 p.
artikel
115 Randomised controlled trial of additional lifestyle support for the reduction of cardiovascular disease risk through primary care in Stoke-on-Trent, UK Davey, Rachel
2010
4 p. 345-354
10 p.
artikel
116 Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: A pilot study Agrawal, Shyam S.
2010
4 p. 272-278
7 p.
artikel
117 Randomized consent designs in randomized controlled trials: Systematic literature search Schellings, Ron
2006
4 p. 320-332
13 p.
artikel
118 Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis Ciccolo, Joseph T.
2012
4 p. 848-852
5 p.
artikel
119 Rationale and design of a trial on the role of bosentan in Fontan patients: Improvement of exercise capacity? Schuuring, Mark J.
2011
4 p. 586-591
6 p.
artikel
120 Rationale and design of the TRANSFACT project phase I: A study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans Chardigny, Jean-Michel
2006
4 p. 364-373
10 p.
artikel
121 Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics Ansley, David M.
2009
4 p. 380-385
6 p.
artikel
122 Recruiting underrepresented groups into the carbohydrates and related biomarkers (CARB) cancer prevention feeding study Coronado, Gloria D.
2012
4 p. 641-646
6 p.
artikel
123 Recruitment for a guided self-help binge eating trial: Potential lessons for implementing programs in everyday practice settings DeBar, Lynn L.
2009
4 p. 326-333
8 p.
artikel
124 Recruitment of lactating women into a randomized dietary intervention: Successful strategies and factors promoting enrollment and retention Stendell-Hollis, Nicole R.
2011
4 p. 505-511
7 p.
artikel
125 Resistance training volume, energy balance and weight management: Rationale and design of a 9month trial Washburn, Richard A.
2012
4 p. 749-758
10 p.
artikel
126 Response to Henneicke-von-Zepelin and Harri Hemilä's comment Bang, Heejung
2005
4 p. 514-515
2 p.
artikel
127 Retention of clinical trial participants in a study of Nongonococcal Urethritis (NGU), a sexually transmitted infection in men Lee, Jeannette Y.
2012
4 p. 606-610
5 p.
artikel
128 Retinitis pigmentosa patients' attitudes toward participation in retinal prosthesis trials Xia, Yu
2012
4 p. 628-632
5 p.
artikel
129 Review of randomised trials using the post-randomised consent (Zelen's) design Adamson, Joy
2006
4 p. 305-319
15 p.
artikel
130 Role for direct electronic verification of pharmaceutical ingestion in pharmaceutical development DiCarlo, Lorenzo A.
2012
4 p. 593-600
8 p.
artikel
131 Sample size calculation for multicenter randomized trial: Taking the center effect into account Vierron, Emilie
2007
4 p. 451-458
8 p.
artikel
132 Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance Chan, Kwun Chuen Gary
2012
4 p. 786-793
8 p.
artikel
133 Starting from scratch: Program development and lessons learned from HIV vaccine trial counseling in Thailand Thapinta, Darawan
2007
4 p. 409-422
14 p.
artikel
134 Stroke Health and Risk Education (SHARE): Design, methods, and theoretical basis Brown, Devin L.
2012
4 p. 721-729
9 p.
artikel
135 The Best Bypass Surgery Trial: Rationale and design of a randomized clinical trial with blinded outcome assessment of conventional versus off-pump coronary artery bypass grafting Møller, Christian H.
2007
4 p. 540-547
8 p.
artikel
136 The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) study Kuller, Lewis H.
2007
4 p. 370-381
12 p.
artikel
137 The Faith, Activity, and Nutrition (FAN) Program: Design of a participatory research intervention to increase physical activity and improve dietary habits in African American churches Wilcox, Sara
2010
4 p. 323-335
13 p.
artikel
138 The “House Calls” Trial: A Randomized Controlled Trial to Reduce Racial Disparities in Live Donor Kidney Transplantation: Rationale and Design Rodrigue, James R.
2012
4 p. 811-818
8 p.
artikel
139 The medication Adherence and Blood Pressure Control (ABC) trial: A multi-site randomized controlled trial in a hypertensive, multi-cultural, economically disadvantaged population Gerin, William
2007
4 p. 459-471
13 p.
artikel
140 The MEMA kwa Vijana Project: Design of a community randomised trial of an innovative adolescent sexual health intervention in rural Tanzania Hayes, Richard J.
2005
4 p. 430-442
13 p.
artikel
141 The primary care osteoporosis risk of fracture screening (POROS) study: Design and baseline characteristics Schneider, Diane L.
2010
4 p. 336-344
9 p.
artikel
142 The process of nutrient analysis for controlled feeding trials: A comparative study of two South African nutrient databases with chemical analysis van der Watt, Izette
2008
4 p. 493-500
8 p.
artikel
143 The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement Mills, Edward J.
2005
4 p. 480-487
8 p.
artikel
144 The Rare Diseases Clinical Research Network Contact Registry update: Features and functionality Richesson, Rachel L.
2012
4 p. 647-656
10 p.
artikel
145 The role of the consent document in informed consent for pediatric leukemia trials Hazen, Rebecca A.
2007
4 p. 401-408
8 p.
artikel
146 The Self-Management of OsteoArthritis in Veterans (SeMOA) Study: Design and methodology Allen, Kelli D.
2008
4 p. 596-607
12 p.
artikel
147 The Smoker's Health Project: A self-determination theory intervention to facilitate maintenance of tobacco abstinence Williams, Geoffrey C.
2011
4 p. 535-543
9 p.
artikel
148 The use of patient-reported outcomes instruments in registered clinical trials: Evidence from ClinicalTrials.gov Scoggins, John F.
2009
4 p. 289-292
4 p.
artikel
149 The views of patients and healthy volunteers on participation in clinical trials: An exploratory survey study Chu, Sang Hui
2012
4 p. 611-619
9 p.
artikel
150 Timing is everything: Methodologic issues locating and recruiting medically underserved women for abnormal mammography follow-up research Fair, Alecia Malin
2008
4 p. 537-546
10 p.
artikel
151 Tobacco dependence counseling in a randomized multisite clinical trial Croghan, Ivana T.
2012
4 p. 576-582
7 p.
artikel
152 Total laparoscopic versus open surgery for stage 1 endometrial cancer: The LACE randomized controlled trial Janda, M.
2006
4 p. 353-363
11 p.
artikel
153 Tracking and tracing of participants in two large cancer screening trials Marcus, Pamela M.
2012
4 p. 601-605
5 p.
artikel
154 Two randomized screening trials with prostate cancer mortality, two interim results Song, Yunjie
2010
4 p. 378-380
3 p.
artikel
155 Use of a precious resource: Parental decision making about using autologous umbilical cord blood in studies involving young children with type 1 diabetes Driscoll, Kimberly A.
2011
4 p. 524-529
6 p.
artikel
156 Using the Internet to search for cancer clinical trials: A comparative audit of clinical trial search tools Atkinson, Nancy L.
2008
4 p. 555-564
10 p.
artikel
157 Validation of treatment induced specific adverse effect as a predictor of treatment benefit: A case study of NCIC CTG BR21 Ding, K.
2008
4 p. 527-536
10 p.
artikel
158 Validity of a point of care device (Cholestech LDX) to monitor liver enzyme activity (aminotransferase measures) during a clinical trial Green, Jody L.
2010
4 p. 279-282
4 p.
artikel
159 Value of an Endpoints Committee versus the use of nosologists for validating cause of death Sesso, Howard D.
2006
4 p. 333-339
7 p.
artikel
160 What predicts non-retention in microbicide trials? Feldblum, Paul J.
2011
4 p. 512-516
5 p.
artikel
                             160 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland